跳至主要内容
临床试验/NCT00774059
NCT00774059撤回不适用

Phase 1 Study to Evaluate the Safety and Performance of the Orbix Breast Lift System

Maastricht University Medical Center2 个研究点 分布在 1 个国家开始时间: 2008年10月16日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Result after using the breast lift system,recurrence of ptosis.

研究概览

简要总结

The study is using a new breast lift system to complement a breast-lift operation.

In general there will be recurrence of breast-ptosis after a correcting operation.

With this device we want to minimize this recurrence and provide an "internal bra".

研究设计

研究类型
Interventional
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
30 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 1.Female subject between 30-50 years of age
  • Subject is referred for mastopexy(breast lifting)due to one of the following reasons:
  • Breast ptosis grade I or II (minimal invasive)
  • Breast ptosis grade I to IV (open procedure)
  • pseudoptosis following breast reduction surgery
  • subject willing to participate as evidenced by signing the written informed consent
  • Minimal invasive: breast cup size <C

排除标准

  • Pregnant or lactating women
  • history of surgical procedures involving the ribs and rib cage
  • Osteoporosis
  • breast implants
  • breast carcinoma
  • auto-immune disease -

结局指标

主要结局

Result after using the breast lift system,recurrence of ptosis.

时间窗: one year

次要结局

  • complications(one year)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Evaluation of Safety and Performance of the Orbix... | 临床试验